Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3

Margin Of Safety %

-30

Put/Call OI Ratio

0.28

EPS Next Q Diff

0.39

EPS Last/This Y

-0.5

EPS This/Next Y

1.12

Price

165.67

Target Price

206.7

Analyst Recom

1.39

Performance Q

8.6

Relative Volume

0.6

Beta

1.65

Ticker: NTRA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25NTRA138.880.4713.4813170
2025-07-28NTRA138.260.531.2013804
2025-07-29NTRA135.810.540.0813950
2025-07-30NTRA140.950.530.1314104
2025-07-31NTRA133.570.520.1614294
2025-08-01NTRA134.510.510.6214405
2025-08-04NTRA136.520.510.4714524
2025-08-05NTRA140.180.500.3415773
2025-08-06NTRA138.060.501.1515834
2025-08-07NTRA141.280.570.8918286
2025-08-08NTRA151.930.590.2019283
2025-08-11NTRA157.120.540.0420264
2025-08-12NTRA159.750.560.0719835
2025-08-13NTRA157.670.540.1020347
2025-08-14NTRA158.480.541.1220328
2025-08-15NTRA163.020.540.7720328
2025-08-18NTRA161.250.311.3314872
2025-08-19NTRA160.050.300.5414967
2025-08-20NTRA160.420.310.0415052
2025-08-21NTRA161.470.270.6116690
2025-08-22NTRA165.580.280.0816728
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25NTRA138.90-98.1-179.2-2.16
2025-07-28NTRA138.25-98.1-183.3-2.16
2025-07-29NTRA135.84-98.1-179.1-2.16
2025-07-30NTRA140.96-98.1-199.9-2.16
2025-07-31NTRA133.66-98.1-165.3-2.19
2025-08-01NTRA134.58-98.1-187.7-2.19
2025-08-04NTRA136.57-98.1-190.6-2.19
2025-08-05NTRA140.12-98.1-195.0-2.19
2025-08-06NTRA138.20-98.1-179.8-2.19
2025-08-07NTRA141.08-98.1-193.3-2.19
2025-08-08NTRA151.95-98.1-214.5-2.19
2025-08-11NTRA157.06-88.3-197.9-2.21
2025-08-12NTRA159.74-51.3-124.1-2.06
2025-08-13NTRA157.70-43.0-47.9-2.04
2025-08-14NTRA158.40-43.0-53.3-2.04
2025-08-15NTRA163.09-43.5-61.1-2.03
2025-08-18NTRA161.16-43.5-48.4-2.03
2025-08-19NTRA160.12-43.4-50.0-2.03
2025-08-20NTRA160.52-43.4-52.7-2.03
2025-08-21NTRA161.96-43.4-54.5-2.03
2025-08-22NTRA165.67-43.4-59.1-2.03
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25NTRA-6.123.472.87
2025-07-28NTRA-6.125.562.82
2025-07-29NTRA-8.635.562.82
2025-07-30NTRA-8.615.562.82
2025-07-31NTRA-8.935.562.82
2025-08-01NTRA-8.245.562.82
2025-08-04NTRA-8.243.332.82
2025-08-05NTRA-7.503.332.82
2025-08-06NTRA-7.703.332.82
2025-08-07NTRA-7.703.332.82
2025-08-08NTRA-7.663.332.82
2025-08-11NTRA-7.663.102.82
2025-08-12NTRA-7.683.103.02
2025-08-13NTRA-7.753.103.00
2025-08-14NTRA-7.673.103.00
2025-08-15NTRA-7.673.103.00
2025-08-18NTRA-7.693.843.00
2025-08-19NTRA-7.753.843.00
2025-08-20NTRA-7.773.843.00
2025-08-21NTRA-7.773.843.00
2025-08-22NTRA-7.773.843.00
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.74

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

-0.35

Insider Transactions

-7.77

Institutional Transactions

3.84

Beta

1.65

Average Sales Estimate Current Quarter

514

Average Sales Estimate Next Quarter

532

Fair Value

115.43

Quality Score

45

Growth Score

63

Sentiment Score

82

Actual DrawDown %

9.5

Max Drawdown 5-Year %

-77.7

Target Price

206.7

P/E

Forward P/E

PEG

P/S

11.57

P/B

18.17

P/Free Cash Flow

217.37

EPS

-1.9

Average EPS Est. Cur. Y​

-2.03

EPS Next Y. (Est.)

-0.91

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-12.89

Relative Volume

0.6

Return on Equity vs Sector %

-45

Return on Equity vs Industry %

-31

EPS 1 7Days Diff

EPS 1 30Days Diff

0.18

EBIT Estimation

-59.1
Natera, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 4424
Natera, Inc., a diagnostics company, provides molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera molecular residual disease test for assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based genomic profiling test, that provides insight into genomic alterations and biomarkers; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product. It serves independent laboratories, national and regional reference laboratories, medical centers and physician practices, research laboratories, and pharmaceutical companies through its direct sales force, and a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
stock quote shares NTRA – Natera, Inc. Stock Price stock today
news today NTRA – Natera, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NTRA – Natera, Inc. yahoo finance google finance
stock history NTRA – Natera, Inc. invest stock market
stock prices NTRA premarket after hours
ticker NTRA fair value insiders trading